Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
INDPthis companyIndaptus Therapeutics, Inc.	$3.35	-0.13×	0.89×	0×	0.27×	137.0%	0.0%	0.0%	0.0%	-661.5%	-629.3%	-527.3%	0×	0.41×	0×	1.51×	0.0%	2	373.3	2	C
AZTRAzitra, Inc.	$0.70	-0.12×	0.34×	0×	0.03×	226.8%	0.0%	0.0%	0.0%	-288.2%	-259.7%	-883.5%	0.11×	0.16×	-1,445.45×	2.83×	0.0%	2	-11.39	3	B-
GTBPGT Biopharma, Inc.	$4.39	-0.13×	0.75×	0×	0.09×	441.2%	0.0%	0.0%	0.0%	-490.0%	-214.7%	-298.3%	0×	0.24×	-97.81×	3.5×	5.3%	1	-185.96	2	C
REVBRevelation Biosciences, Inc.	$4.00	-0.13×	0.22×	0×	0.88×	2518.1%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-416.3%	0.08×	1.1×	0×	5.41×	0.0%	2	-7.62	2	B-
Peer median	—	-0.13×	0.34×	0×	0.09×	441.2%	0.0%	0.0%	0.0%	-288.2%	-214.7%	-416.3%	0.08×	0.24×	-97.81×	3.5×	0.0%	2	-11.39	2	—